Ads Top

Using RFID Technology to Ensure the Traceability of French Plasma for Fractionation

The LFB group, Biolog-id and the French Blood Transfusion Service (Etablissement Français du Sang/EFS) have announced the introduction of an RFID1 traceability system developed by Biolog-id for LFB. All bags containing plasma for fractionation leaving EFS centres will henceforth incorporate RFID chips, which will facilitate their registration at LFB, the only company fractionating this plasma.

The system developed by Biolog-id for tracking and tracing blood products using RFID, has been selected by LFB for use in managing, storing and monitoring all bags containing plasma for fractionation, that leave EFS centres in France2, to be fractionated by LFB in order to produce medicinal products. Biolog-id is the first operator in the world to offer this kind of overall traceability solution for blood products. And its solution has been selected by LFB for tracking all EFS bags containing plasma for fractionation.

Introducing the system is a joint initiative involving LFB, Biolog-id and the EFS, the solution having been co-developed by Biolog-id and LFB.

RFID labelling was authorised by the French National Agency for Medicines and Health Products Safety (Agence Nationale de Sécurité du Médicament/ANSM) on July 26, 2012, and the technology will henceforth be used in all 14 regional branches of the EFS in mainland France.

1 comment:

  1. healthcare and manufacturing constitute some of the most rapidly expanding sectors that would be instrumental in propelling demand for RFID technology in the years to come.


    Rfid Market Research

    ReplyDelete

Powered by Blogger.